Cargando…
Practical recommendations for the use of therapeutic drug monitoring of biopharmaceuticals in inflammatory diseases
Biopharmaceuticals directed against tumor necrosis factor-alpha, integrins, interleukins, interferons and their receptors have become key agents for the management of inflammatory diseases in the fields of gastroenterology, rheumatology, dermatology and neurology. However, response to these treatmen...
Autores principales: | Dreesen, Erwin, Bossuyt, Peter, Mulleman, Denis, Gils, Ann, Pascual-Salcedo, Dora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5633318/ https://www.ncbi.nlm.nih.gov/pubmed/29042821 http://dx.doi.org/10.2147/CPAA.S138414 |
Ejemplares similares
-
Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
por: Krieckaert, Charlotte, et al.
Publicado: (2022) -
Editorial: Therapeutic Drug Monitoring (TDM): A Useful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice
por: Simeoli, Raffaele, et al.
Publicado: (2022) -
Adalimumab concentration-based tapering strategy: as good as the recommended dosage
por: Mulleman, Denis, et al.
Publicado: (2018) -
Correction: Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
Publicado: (2022) -
Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology
por: Verheijen, Remy B., et al.
Publicado: (2017)